×
  • Category
  • Type
  • Advanced

Annexes to the recommendations for use of the CanSinoBIO Ad5-nCoV-S [‎recombinant]‎ vaccine (‎Convidecia™)‎ against COVID-19

Interim recommendations for use of the CanSinoBIO Ad5-nCoV-S [‎recombinant]‎ vaccine (‎Convidecia™)‎ against COVID-19

Background document on the CanSinoBIO Ad5-nCoV-S [‎recombinant]‎ vaccine (‎ConvideciaTM)‎ against COVID-19

Ultra-Cold Chain (UCC) – Pfizer covid19 Vaccine Logistics Training and TA

Ultra-low temperature vaccine management

COVID-19 Maternal Immunization Resource Library

Chaine Ultra-Froid du Vaccin Pfizer (UCC) - Plateforme d'Assistance Technique

Pfizer vaccine ultra cold chain (ucc) - Technical Assistance Platform

Q&A on the webinar: Pfizer BioNTech COVID-19 Vaccine new formulation: implications on vaccine management, supply chain, and technical assistance

Presentation on Pfizer BioNTech COVID-19 Vaccine new formulation: implications on vaccine management, supply chain, and technical assistance

Webinaire sur la nouvelle formulation du vaccin Pfizer BioNTech contre la COVID-19 : incidences sur la gestion du vaccin, la chaîne d’approvisionnement et l’assistance technique

Questions-réponses : les vaccins anti-COVID-19 et la grossesse

COVID-19 vaccine delivery in LMICs: How to think about concentration vs dispersion in delivery?

Injection safety in the context of coronavirus disease (COVID-19) vaccination

Missed routine pediatric care and vaccinations in US children during the first year of the COVID-19 pandemic

Impact of the COVID-19 Pandemic on Human Papillomavirus Vaccination in Brazil

Options de stratégies d'administration du vaccin COVID-19

Recommandations provisoires concernant l’utilisation du vaccin ChAdOx1-S [‎recombinant]‎ contre la COVID-19 (‎vaccin anti-COVID-19 d’AstraZeneca AZD1222 Vaxzevria™, SII COVISHIELD™)‎

Recommandations provisoires pour l’utilisation du vaccin anti-COVID-19 inactivé BIBP développé par China National Biotec Group (‎CNBG)‎, Sinopharm

Recommandations provisoires pour l’utilisation du vaccin anti-COVID-19 BBV152 COVAXIN® de Bharat Biotech